A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure

Vaccine

Volumn 24, Issue 26, 2006, Pages 5481-5490

  Antonis, Adriaan F G ^a   Bruschke, Christianne J M ^a   Rueda, Paloma ^b   Maranga, Luis ^c   Casal, J Ignacio ^b   Vela, Carmen ^b   Hilgers, Luuk A Th ^d   Belt, Peter B G M ^a   Weerdmeester, Klaas ^a   Carrondo, Manuel J T ^c   Langeveld, Jan P M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Inmunologia y Genetica Aplicada SA   (Spain)

^c Inst de Biol Exp e Tecologica   (Portugal)

^d CoVaccine BV ^*  (Netherlands)

Author keywords

Porcine parvovirus; Recombinant; Vaccine; Virus like particles

Indexed keywords

ADJUVANT; CARBOMER; CYCLODEXTRIN DERIVATIVE; DILUVAC FORTE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; MINERAL OIL; PORCILLIS PARVO; RECOMBINANT VACCINE; SORBITAN TRIOLEATE; SPECOL; SUBUNIT VACCINE; SULPHOLIPO CYCLODEXTRIN; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; FEMALE; GUINEA PIG; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PRIORITY JOURNAL; REPRODUCTION; REPRODUCTIVE TOXICITY; SWINE; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, PORCINE; PREGNANCY; SWINE; SWINE DISEASES; VIRAL VACCINES;

EID: 33744826259     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.089     Document Type: Article

References (42)

1. Ranz A.I., Manclus J.J., Diaz-Aroca E., and Casal J.I. Porcine parvovirus: DNA sequence and genome organization. J Gen Virol 70 10 (1989) 2541-2553
2. Siegl G., Bates R.C., Berns K.I., Carter B.J., Kelly D.C., Kurstak E., et al. Characteristics and taxonomy of Parvoviridae. Intervirology 23 2 (1985) 61-73
3. Paradiso P.R., Rhode S.L., and Singer II. Canine parvovirus: a biochemical and ultrastructural characterization. J Gen Virol 62 1 (1982) 113-125
4. Mengeling W.L., and Cutlip R.C. Reproductive disease experimentally induced by exposing pregnant gilts to porcine parvovirus. Am J Vet Res 37 12 (1976) 1393-1400
5. Mengeling W.L., Lager K.M., and Vorwald A.C. The effect of porcine parvovirus and porcine reproductive and respiratory syndrome virus on porcine reproductive performance. Anim Reprod Sci 60-61 2 (2000) 199-210
6. Kim J., Chung H.-K., and Chae C. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet J 166 3 (2003) 251-256
7. Allan G.M., Kennedy S., McNeilly F., Foster J.C., Ellis J.A., Krakowka S.J., et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 121 1 (1999) 1-11
8. Ellis J.A., Bratanich A., Clark E.G., Allan G., Meehan B., Haines D.M., et al. Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome. J Vet Diagn Invest 12 1 (2000) 21-27
9. Joo H.S., Donaldson-Wood C.R., and Johnson R.H. Observations on the pathogenesis of porcine parvovirus infection. Arch Virol 51 1-2 (1976) 123-129
10. Christianson W.T. Stillbirths, mummies, abortions, and early embryonic death. Vet Clin N Am Food Anim Pract 8 3 (1992) 623-639
11. Cutlip R.C., and Mengeling W.L. Experimentally induced infection of neonatal swine with porcine parvovirus. Am J Vet Res 36 08 (1975) 1179-1182
12. Parke C.R., and Burgess G.W. An economic assessment of porcine parvovirus vaccination. Aust Vet J 70 5 (1993) 177-180
13. Paul P.S., Mengeling W.L., and Brown Jr. T.T. Effect of vaccinal and passive immunity on experimental infection of pigs with porcine parvovirus. Am J Vet Res 41 9 (1980) 1368-1371
14. Maranga L., Cruz P.E., Aunins J.G., and Carrondo M.J. Production of core and virus-like particles with baculovirus infected insect cells. Adv Biochem Eng Biotechnol 74 (2002) 183-206
15. Lopez de Turiso J.A., Cortes E., Martinez C., Ruiz de Ybanez R., Simarro I., Vela C., et al. Recombinant vaccine for canine parvovirus in dogs. J Virol 66 5 (1992) 2748-2753
16. Martinez C., Dalsgaard K., Lopez de Turiso J.A., Cortes E., Vela C., and Casal J.I. Production of porcine parvovirus empty capsids with high immunogenic activity. Vaccine 10 10 (1992) 684-690
17. Rueda P., Fominaya J., Langeveld J.P., Bruschke C., Vela C., and Casal J.I. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 19 7-8 (2000) 726-734
18. Casal J.I. Use of parvovirus-like particles for vaccination and induction of multiple immune responses. Biotechnol Appl Biochem 29 2 (1999) 141-150
19. Simpson A.A., Hebert B., Sullivan G.M., Parrish C.R., Zadori Z., Tijssen P., et al. The structure of porcine parvovirus: comparison with related viruses. J Mol Biol 315 5 (2002) 1189-1198
20. Maranga L., Cunha A., Clemente J., Cruz P., and Carrondo M.J. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. J Biotechnol 107 1 (2004) 55-64
21. Maranga L., Rueda P., Antonis A.F., Vela C., Langeveld J.P., Casal J.I., et al. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 59 1 (2002) 45-50
22. Maranga L., Brazao T.F., and Carrondo M.J. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84 2 (2003) 245-253
23. Bokhout B.A., van der Heijden P.J., Nabuurs M.J., and Bianchi A.T. Research of the application of a water-in-oil emulsion for the prevention of post-weaning diarrhoea and oedema disease in piglets. Comp Immunol Microbiol Infect Dis 9 2-3 (1986) 277-283
24. Hilgers L.A., Lejeune G., Nicolas I., Fochesato M., and Boon B. Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant. Vaccine 17 3 (1999) 219-228
25. Hilgers L.A., Nicolas I., Lejeune G., Dewil E., and Boon B. Effect of various adjuvants on secondary immune response in chickens. Vet Immuno Immunopathol 66 2 (1998) 159-171
26. Hilgers L.A., Nicolas I., Lejeune G., Dewil E., Strebelle M., and Boon B. Alkyl-esters of polyacrylic acid as vaccine adjuvants. Vaccine 16 16 (1998) 1575-1581
27. Kamstrup S., Langeveld J., Botner A., Nielsen J., Schaaper W.M., Boshuizen R.S., et al. Mapping the antigenic structure of porcine parvovirus at the level of peptides. Virus Res 53 2 (1998) 163-173
28. Botner A., Nielsen J., and Bille-Hansen V. Isolation of porcine reproductive and respiratory syndrome (PRRS) virus in a Danish swine herd and experimental infection of pregnant gilts with the virus. Vet Microbiol 40 3-4 (1994) 351-360
29. Sedlik C., Saron M., Sarraseca J., Casal I., and Leclerc C. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T-cells. Proc Natl Acad Sci USA 94 14 (1997) 7503-7508
30. Noad R., and Roy P. Virus-like particles as immunogens. Trends Microbiol 11 9 (2003) 438-444
31. Stanbridge L.J., Dussupt V., and Maitland N.J. Baculoviruses as vectors for gene therapy against human prostate cancer. J Biomed Biotechnol 2003 2 (2003) 79-91
32. Liang C.Y., Wang H.Z., Li T.X., Hu Z.H., and Chen X.W. High efficiency gene transfer into mammalian kidney cells using baculovirus vectors. Arch Virol 149 1 (2004) 51-60
33. Facciabene A., Aurisicchio L., and La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78 16 (2004) 8663-8672
34. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347 21 (2002) 1645-1651
35. Stanley M.A. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection. Expert Rev Vaccines 2 3 (2003) 381-389
36. Ball J.M., Graham D.Y., Opekun A.R., Gilger M.A., Guerrero R.A., and Estes M.K. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterologia 117 1 (1999) 40-48
37. Tacket C.O., Sztein M.B., Losonsky G.A., Wasserman S.S., and Estes M.K. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 108 3 (2003) 241-247
38. Martinez-Torrecuadrada J.L., Saubi N., Pages-Mante A., Caston J.R., Espuna E., and Casal J.I. Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 21 23 (2003) 3342-3350
39. Roy P., Bishop D.H., LeBlois H., and Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12 9 (1994) 805-811
40. Leenaars M., Claassen E., and Boersma W.J.A. Antigens and antigen presentation. In: Lefkovits I. (Ed). Immunology methods manual 2 (1997), Academic Press, San Diego 991-1013
41. Hilgers L.A., and Snippe H. DDA as an immunological adjuvant. Res Immunol 143 5 (1992) 494-503
42. European pharmacopoeia, European Directorate for the Quality of Medicines, Strasbourg, 2004.